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Abstract: Recent advances in natural products chemistry and phytomedicine research 
has been aimed at novel lipid based drug delivery systems. Herbosome technology is 
one of such systems that incorporate phospholipids into standardized active ingredients 
of herbal extracts, thus effectively enhancing the bioavailability of water-soluble 
bioactive constituents of phytomedicines such as flavonoids, phenolics and hydrophilic 
compounds. These phytoconstituents have been established to exhibit a variety of 
biological activities that have pharmacological benefits. However, poor absorption of 
these phytoconstituents limits their bioavailability. The poor absorption is principally 
due to the failure of these constituents to reach their site of action before being 
degraded as well as their inability to pass through the small intestine due to their multi 
ring structures and the lipid nature of the intestinal wall. This review chronicles the 
recent advances made in herbosome technology, highlighting the concepts, applications 
and future perspective of herbosome use. 
Key words: Herbosomes, Phytomedicine, Lipid based delivery systems, Phytosomes, 
Phyto-phospholipid complex. 
 
Introduction 
Phytomedicines have been used for 
the treatment of various ailments 
since ancient times. In recent years 
there has been an increase in 
research output relating to natural 
products chemistry especially in 
Nigeria and Africa in general. 
Various plant materials have been 
observed to exhibit a variety of 
biological activity such as 
antilipidemic activity, 
hepatoprotective activity, 
immunomodulatory activity etc. 
Currently, as many as one-third to 
approximately one-half of all the 
drugs available are derived from 
plants or other natural sources [1]. 
The drug formulations of traditional 
systems of medicine like the African, 
Chinese and Indian systems usually 
contain crude extracts of different 
herbs which incorporate in them 
undesirable and many times, toxic 
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principles along with the active 
principles. With the developments in 
the field of phyto- and analytical 
chemistry, specific ingredients or a 
group of similar ingredients from 
plants are being extracted, isolated 
and tested for their different 
therapeutic applications [2]. The 
bioactive components of these herbs 
have been identified as mostly 
flavonoids, tannins, glycosides, 
phenolics and other hydrophilic 
molecules. Nevertheless, isolation 
and purification of individual 
components from whole herbal 
extracts often lead to partial or total 
loss of therapeutic activity. The 
chemical complexity of the crude or 
partially purified extract appears to 
be crucial for the bioavailability of 
the active constituents; hence 
standardization of herbal extracts has 
become imperative [3]. 
Although having excellent 
bioactivity in vitro, plant extracts 
often exhibit poor effectiveness in 
vivo or in animal models. The basic 
reasons for the low bioavailability of 
herbal extracts are that the bioactive 
components of these herbs possess 
multi- ring molecular structures 
which cannot be absorbed into the 
blood by simple passive diffusion 
and the bioactive phytoconstituents 
are mostly water soluble, hence, their 
poor lipid solubility limits their 
ability to pass across lipid 
biomembranes. This has restricted 
the use of pharmacologically 
effective polyphenolic plant actives 
for treating different disorders. 
Moreover, when taken orally, 
bioactive phytoconstituents are 
destroyed by or lost to the gastric 
environment or they may be 
rendered less effective by interaction 
with other drugs or nutraceuticals 
[4]. 
To counter these problems 
pharmaceutical research has been 
geared towards the development of 
novel lipid-based drug delivery 
systems to improve the 
bioavailability of drugs while 
maintaining the therapeutic activity 
of the drug. One delivery system 
designed to improve the in vivo 
solubility and hence bioavailability 
of poorly soluble herbal drugs 
involves the incorporation of 
standardized herbal extracts into 
phospholipids to form a ―lipid- 
friendly‖ complex called a 
herbosome or phytosome [5][6]. In 
view of their ampiphilic properties, 
herbosomes are more bioavailable 
(as demonstrated by 
pharmacokinetics and activity 
studies in animals), when applied 
topically or orally, as compared with 
simple herbal extracts owing to their 
enhanced capacity to cross into the 
blood through the lipid-rich 
biomembranes [3][6]. The active 
components of herbal formulation 
are also well protected from 
destruction by the gastric 
environment [7]. 
Lipid drug delivery systems have 
advantages over polymer based 
systems. The advantages include: 
heightened drug absorption, reduced 
side effects, controlled drug release 
and site specific targeting. Also, 
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most lipid formulations have high 
stability, high carrier capacity, 
feasibility of incorporation of both 
hydrophilic and hydrophobic 
substances, and feasibility of 
variable routes of administration [7]. 
Properties and Morphology of 
Herbosomes 
The term ―phyto/herb‖ refers to 
plants while ―some‖ means cell-
like. Herbosomes are lipid 
compatible molecular complexes. 
They are lipophilic substances with a 
clear melting point. They are freely 
soluble in nonpolar solvents (in 
which the hydrophilic drug moiety 
are not), and moderately soluble in 
fats. When treated with water, 
herbosomes assume a micellar shape 
forming liposomal-like structures. 
The size of the phyto- phospholipid 
complex molecules customarily 
varies from 50 nm to about 500 μm. 
In herbosomes, phytomolecules are 
anchored through chemical bonds to 
the polar head of the phospholipids. 
Molecular imaging and NMR studies 
of phyto-phospholipid complexes 
show one or more 
phosphatidylcholine molecules 
effectively embedded with a 
polyphenol molecule and it has been 
shown that the main phospholipid-
substrate interaction is due to the 
formation of hydrogen bonds 
between the polar head of 
phospholipids (i.e. phosphate and 
ammonium groups) and the polar 
functional groups of the substrate 
[6]. Some researchers had also 
suggested the formation of Van der 
Waals forces between the two 
moieties. It has been proposed that 
the aqueous head of 
phosphatidylcholine molecule i.e. the 
choline binds to the water-soluble 
compounds and the phosphatidyl 
portion being lipophilic encloses the 
choline bound structure. [2]. 
Pharmacokinetic and 
pharmacodynamic studies in 
experimental animals and in human 
subjects have been used to 
demonstrate the biological behavior 
of herbosomes [8]. The increased 
bioavailability of the phytosomes 
over the non complexed botanical 
derivatives has been evaluated from 
these studies. The studies suggest 
that most of the drugs having crystal 
structure when complexed with 
phospholipids get transformed into 
molecularly dispersed or amorphous 
form. The X-ray diffraction pattern 
of drug and drug–phospholipid 
physical mixture in almost all the 
studies has shown crystalline peaks, 
which disappear in the diffraction 
pattern of the drug–phospholipid 
complexes. The improved lipid 
solubility of the herbosome 
complexes has been attributed to this 
change of crystalline state. The 
herbosome complexes of different 
drug molecules have been shown to 
be slightly spherical in shape with a 
rough surface morphology and good 
flow properties [2]. Herbosomes are 
different from liposomes, and are not 
to be confused with them. In 
liposomes the active principle is 
dissolved in the medium in the cavity 
or internal pocket or floats in the 
layer membrane, while in 
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phytosomes the active principle is 
anchored to the polar head of 
phospholipids, becoming an integral 
part of the membrane [3]. 
Merits of the Herbosome System 
1. Enhanced Bioavailabilty, 
Systematic Absorption and Assured 
Delivery to the Target Site: 
herbosomes provide an actual means 
of improving the use of herbal 
formulations as herbosomes are 
liable to get transported across the 
lipophilic environment of cell 
membranes, into the cell and 
eventually into the blood. There is 
improved intestinal lumen absorption 
of the extracts as well as better 
permeation of the extracts through 
the skin for dermal and transdermal 
delivery. 
Due to enhanced bioavailability, the 
dose of phytoconstituents required to  
 
produce a desired effect is reduced. 
The duration of action is also 
increased. Herbosomes are more 
stable in the gastric environment and 
resist the action of gut microbes. 
Furthermore, drug entrapment is not 
a problem with herbosomes, as the 
complex is biodegradable [3][9]. 
2. Safety: the herbosome system is 
passive and non-invasive. The 
components of the herbosome are 
non-toxic and non-mutagenic and 
they have been approved for 
pharmaceutical and cosmetic use 
[2][6]. The conventional approaches 
for preparing the herbosome 
complexes using harmful organic 
solvents like tetrahydrofuran and 
dichloromethane have now been 
widely replaced by the hydrophilic 
solvents liethanol, thus increasing 
their safety and potential for use in 
clinical applications. 
 
 
3. Other additional benefits: The 
process of manufacturing 
herbosomes is relatively simple, with 
no complicated technical 
investments required. Herbosome 
technology has no large drug 
development risk since the 
toxicological profiles of its 
component are well documented in 
scientific literature [6]. 
The phospholipids employed in 
herbosome formulation, apart from a 
physiologically compatible 
pharmacokinetic and toxicological 
profile, also possess some 
medicinally significant properties in 
human. Phospholipids add to the 
nutritional value of the plant extract 
like phosphatidylserine, which acts 
as a brain cell nutrient.  
   13 
 
Covenant Journal of Physical and Life Sciences (CJPL) Vol. 3 No 2. December, 2015. 
 
. 
Phospholipids are a good source of 
phosphatidylcholine and choline, 
both of which liquefy the fat 
deposited in the liver as in case of 
hepatic steatosis or fatty liver. Soya 
phospholipids have been shown to be 
hepatoprotective in nature, 
preventing liver damage by alcohol 
drugs and other toxins thus providing 
a synergistic effect for liver 
protection. They have also been 
reported to 
aid in clearance of serum cholesterol 
and increase circulating HDL levels 
in plasma. [2][10][11]. 
Phospholipids such as phosphatidyl 
choline show unique compatibility 
with biological membranes. 
phosphatidylcholine have shown to 
be incorporated in the cell membrane 
to replace cellular phospholipids and 
thus affect the fluidity of the 
membrane hence they maintain and 
nourish the skin. 
Furthermore, the low solubility of 
herbosomes in aqueous media allows 
for the formulation of stable 
emulsions and creams. 
The Phospholipid Complexation 
Technique (Herbosome 
Formulation) 
Herbosome is a patented process, 
developed in the year 1989 by 
Indena, an Italian pharmaceutical 
and neutraceutical company. They 
patented the technology 
as    T     ®.This phytosome 
is a cell like structure, which is a 
combination of soy lecithin with 
standardized extracts containing 
polyphenolic compounds, which had 
vastly improved their absorption and 
utilization [2]. Herbosomes result 
from the chemical reaction of a 
stoichiometric amount of the 
phospholipid to the standardized 
herb extract or specific active 
phytoconstituents and are generally 
prepared by solvent evaporation or 
anti solvent precipitation techniques 
using alcoholic or organic solvents 
as reaction media. The supercritical 
fluid technique has also been 
incorporated into herbosome 
technology (for preparing puerarin–
phospholipid complex) by 
researchers such as Li and coworkers 
[12]. In the more frequently used 
solvent evaporation technique the 
drug (standardized extract or isolated 
bioactive phytoconstituents) and the 
phospholipids are placed in the same 
flask containing a suitable solvent 
system. The reaction is carried out at 
suitable fixed temperature for a fixed 
duration of time to get maximum 
possible yield and drug entrapment 
[2]. The optimum ratio of 
phospholipid to drug is 1:1 although 
different molar ratios ranging from 
0.5:1 to 3:1 have also been employed 
with success [13][14]. The 
herbosome complex thus formed can 
be isolated by precipitation with an 
aliphatic hydrocarbon or 
lyophilization or spray drying [15]. 
The common stages for the 
preparation of herbosomes are shown 
in Fig. 3. Usually, Aprotic solvents 
like acetone, methylene chloride, 
ethyl acetate, dioxane etc. are used as 
reaction media for formulating 
herbosomes, however they have been 
largely replaced by protic solvents 
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like ethanol. Other Solvents such as 
tetrahydrofuran, dichloromethane 
and n-hexane have also been used by 
researchers [13][16][17]. Most of the 
recent works have been carried out 
using absolute ethanol as the reaction 
medium. 
The common criterion for selection 
of phospholipids for herbosome 
formulation was the ratio of 
phosphatidyl group present in them 
.The most commonly used 
phospholipids are those derived from 
soya bean containing higher 
proportions (that is about 76%) of 
phosphatidylcholine with a high 
content of polyunsaturated fatty 
acids like linoleic acid about 70%, 
linolenic acid and oleic acid. The 
phospholipids of soya bean have 
been the phospholipid of choice 
because of the higher content of 
phosphatidylcholine in them offers 
compatibility and similarity with the 
mammalian plasma membrane [2]. 
Soy lecithin, phosphatidylserine, and 
1,2-distearoyl-sn-glycero-3- 
phosphocholine have also been used. 
Evaluation and Characterization 
of Herbosomes 
Factors such as size, membrane 
permeability, the amount and purity 
of preparatory materials, the 
percentage of entrapped 
phytochemicals and chemical 
composition, determine how a 
herbosome would behave in a 
biological system. A variety of 
techniques have been employed for 
the study and characterization of 
herbosomes. 
Transmission Electron Microscopy 
and Scanning Electron Microscopy 
have been used to visualize the 
herbosome after formation to assess 
its size and shape. The formation of 
the phyto-phospholipid complex can 
be confirmed by FTIR spectroscopy, 
X-ray diffraction, NMR and 
Molecular imaging techniques while 
the drug content of the of the 
complex can be quantified used 
HPLC. Other techniques used 
include Dynamic light scattering 
(DLS) coupled with a computerized 
inspection system and Photon 
correlation spectroscopy, to 
determine the particle size and Zeta 
potential of the complex and 
Ultracentrifugation to determine the 
entrapment efficiency of an extract 
by a herbosome. 
Applications of Herbosomes 
Herbosomes formulations in 
solutions, emulsions, creams, lotions, 
gels etc., have gained importance in 
various fields like the 
pharmaceutical, veterinary, cosmetic 
and nutraceutical fields. 
Companies involved in production 
and marketing of herbosomal 
products include, Indena in Milan, 
Italy; Jamieson Natural Sources in 
Ontario, Canada; Thorne Research in 
Dover, England and Natural Factors 
in Canada. 
The herbosome process has been 
applied to many popular herbal 
extracts including Gingko bilboa, 
grape seed, hawthorn, olive fruits 
and leaves, green tea, ginseng, 
kushenin, marsupsin and curcumin 
[7]. These phytosomes are 
significantly more bioavailable and 
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hence therapeutically more effective 
than the standardized extracts or 
their conventional forms and are 
useful in various disorders. 
Maiti et al. [18], have demonstrated 
the improvement in pharmacokinetic 
profile of curcumin on carbon 
tetrachloride-induced acute liver 
damage in rats by preparing its 
complexation with phospholipids. 
The antioxidant activity of the 
herbosome was significantly higher 
than that of pure Curcumin at all 
dose levels tested [2][6][18] 
Maiti et al. [19], also demonstrated 
the improvement in pharmacokinetic 
profile of naringenin herbosome. The 
developed naringenin herbosome 
exhibited better antioxidant activity 
than the free compound with a 
prolonged duration of action. [6][19]. 
Yanyu et al. have evaluated the 
bioavailability of silybin– 
phospholipid complex against 
silybin-N- methylglucamine. The 
phospholipid complex showed 
prolonged plasma therapeutic level 
and increased bioavailability [20]. 
Chen et al. [21], have demonstrated 
the pharmacokinetic profile of 
quercetin,kaempferol and 
isorhamnetin present in Ginkgo 
biloba extract after 
oraladministration in rats by 
formulating its phospholipid 
complex. The results demonstrated 
an immense increase in 
bioavailability of the extract in its 
phospholipid complexed form 
[2][21]. 
 
 
Other therapeutically efficient 
phytosome complexes from different 
plant extracts/ active compounds 
developed in recent years are 
summarized in Table 1 along with 
the improvement in 
pharmacodynamic and 
pharmacokinetic profiles of the crude 
drug and their clinical utility. 
Herbosome Technology in Nigeria 
One of the most prevalent fields of 
research in Nigeria is 
ethnopharmacology and Natural 
Products Chemistry. There is a 
wealth of literature and research 
findings on the pharmacology of a 
wide variety of medicinal and lesser 
known plants found in Nigeria. 
Bioactive phytoconstituents are 
being discovered yearly, not only in 
new medicinal plants but in those 
that have already been investigated. 
Bioactive phytochemicals that have 
been identified include: flavonoids, 
glycosides, terpenes, lectins, 
alkaloids, tannins and saponins. 
Crude extracts of plant materials as 
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well as isolated bioactive derivatives 
have been studied and observed to 
have such exploitable biological 
properties including 
antihyperlipidemic, allelopathic, 
antisickling and hepatoprotective 
effect. 
Still, in order for these plant products 
to be useful clinically, it is necessary 
to have appropriate formulations and 
delivery systems, which provide 
optimum delivery of the active 
ingredients. Unfortunately, in spite 
of the wealth of scientific data and 
literature available on the medical 
significance of a vast number of 
Nigerian plants, there is little or no 
data or research carried on ideal 
delivery systems for these herbal 
products. There is no data available 
on the use of herbosomes for herbal 
drug formulations in Nigeria, in spite 
of the recorded improvement in 
pharmacodynamic and 
pharmacokinetic profiles of herbal 
drugs and isolated bioactive 
components when complexed with 
phospholipids. Hence, plant extracts 
are still being administered in 
extremely large doses and the 
possibility exists that some herbal 
plants which have great clinical 
significance been judged ineffective 
due to their low bioavailability. 
Future Perspectives and 
Conclusion 
Herbosomes improve the in vivo 
bioavailability of herbal drugs, 
which in spite of positive in vitro 
results fail to deliver a similar 
response in vivo. The hydrophilic 
constituents of plants like flavonoid 
and others polyphenolic constituents 
have immense therapeutic potential 
but because of their inability to cross 
lipoidal barriers their application in 
treatment of several disorders and 
disease conditions. The incorporation 
of these phytoconstituents with 
dietary phospholipids has 
successfully solved this issue and has 
offered a preparation of herbal drugs 
with sufficient lipid penetrability, 
higher concentration and sustained 
therapeutic levels in plasma with a 
slower rate of elimination. 
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To further justify herbosomes as a 
productive novel lipid-based drug 
delivery system, the scope of the 
research needs to be broadened to 
solve the issues of the preparation 
technique, complex stability after 
preparation, mechanism of 
absorption and actual clinical 
advantage of these drug delivery 
systems. The solvent evaporation 
technique, which is the frequently 
used technique for formulating 
herbosomes, involves a number of 
processing steps, which are time 
consuming. Furthermore, the quality 
of the end product in terms of 
particle size, morphology and 
hygroscopicity many times depends 
upon the method adopted for drying 
of the residue, which has not been 
optimized in any of the studies. To 
counter these problems, techniques 
such as the supercritical fluid 
technique, which has emerged as an 
effective tool for preparing particle 
sizes ranging from 5 to 2000nm and 
which has been utilized for 
improving the solubility profile of 
poor soluble drug molecules can be 
incorporated to overcome the 
drawbacks of conventional methods 
as the particle size and its 
distribution can be more precisely 
controlled at very mild temperature 
conditions. The uniformity in 
particle size further improves the 
systemic bioavailability [2]. The 
CO2 supercritical fluid is 
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nonhazardous and provides stable 
inert conditions for processing of 
sensitive drug molecules. Hence, 
further research work for formulation 
optimization using the supercritical 
fluid technique and its impact on in 
vivo parameters of herbal drugs need 
to be carried out. 
The yield of the herbosome 
complexes obtained from various 
studies varied significantly ranging 
from about 25% to more than 90%. 
These variations have been attributed 
to different formulation factors like 
drug to phospholipid ratio, 
temperature and duration of 
processing. These aspects of the 
formulation have to be optimized in 
future research works to get the 
formulation of best quality. 
Furthermore, statistical tools can be 
used for optimizing the molar ratios 
of drug candidates with 
phospholipids, along with the 
temperature and other variables to 
get maximum entrapment efficiency 
and a superior drug release profile 
[2]. 
Emphasis has been given on the 
characterization and evaluation of 
pharmacokinetic parameters of 
phyto-phospholipid complexes 
without going in to the clinical 
aspects of prepared formulations. 
More exhaustive studies establishing 
correlation between improvement of 
in vivo and in vitro pharmacokinetic 
parameters with the pharmacological 
efficacy of drug molecules in their 
phospholipid complexed forms are 
required to fill this gap and to 
correlate the improvement in 
bioavailability with clinical efficacy 
[2].
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The stability of the herbosomal 
complexes are another area of which 
needs more attention and 
exploration. The data in support of 
the stability of the phyto-
phospholipid complexes on storage 
are insufficient in terms of their 
market utility and survival. Such 
preparations are at risk of aggregate 
formation and chemical degradation 
on storage [2]. Preparations with 
more than 90% purity of 
phospholipids are considered to be 
more susceptible for oxidative 
changes, which may be a decisive 
factor in terms of stability of the 
final product. Zeta potential plays a 
key role in determining stability of 
solid dispersions and inter-particle 
interactions and so is temperature 
related hygroscopicity of the 
formulations [2]. Experimental work 
has revealed strong moisture 
absorbing potential of the 
phytophospholipid complexes when 
compared with pure drug and the 
formulation has also exhibited to 
become more viscous when kept in 
free air [14]. These parameters have 
remained more or less untouched in 
most of the studies and require more 
emphasis in the future to establish 
and improve the stability of the 
phyto-phospholipid complexes. 
The exact mechanism of absorption 
of the drug– phospholipid complexes 
from the gastrointestinal tract should 
be an area of focus in future 
research. In conclusion, in order to 
be clinically useful, the vast number 
of plant products being isolated and 
studied in countries such as Nigeria, 
need to have appropriate 
formulations and optimum drug 
delivery systems for the polar 
bioactive ingredients. Herbosome 
technology aids to explore maximum 
potential of these polar 
phytoconstituents. The formulation 
technology is simple and can be 
easily upgraded to a commercial 
scale and the components of the 
herbosome are relatively safe. 
Hence, several plant extracts which 
have been reported to possess 
various pharmacological and health 
promoting properties but which show 
poor bioavailability can be 
standardized and formulated into 
herbosomes for further systematic 
studies and clinical application. 
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